Curcumin nanoparticles show promise in treating neurodegenerative diseases

FHS
June 7, 2024
3:18 am

Review demonstrates curcumin’s neuroprotective effects in neurodegenerative diseases, enhancing its potential through innovative nanoparticle formulations. This advancement could significantly improve treatments for diseases like Parkinson’s, Alzheimer’s, and Multiple Sclerosis.

Teladoc’s long-time CEO is leaving

(This story is from our new Health Tech newsletter. If you’d like to sign up, just click here.) Teladoc Health’s CEO Jason Gorevic is stepping

April 6, 2024

New federal rules demand transparency into AI models used in health decisions

Federal health technology regulators on Wednesday finalized new rules to force software vendors to disclose how artificial intelligence tools are trained, developed, and tested —

December 13, 2023

Riding the wave on latest obesity buyout; Slack interview with anti-aging researcher; Two new IRA lawsuits; and more

Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit

August 27, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.